Post-hoc analyses revealed significant discrepancy in 1,5-AG change between T2DM and HNF1A-MODY (p = 0.04) and a borderline difference between T2DM and GCK-MODY (p = 0.07). The gene discussed is HNF1A; the disease is type 2 diabetes mellitus.